Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Relapse from Complete Remission More Than 5 Years after Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Relapse Histology Most Commonly DLBCL with a Germinal Center B-Cell (GCB) Phenotype.

Julie M. Vose, MD, John C. Chan, MD, Philip J. Bierman, MD, Alejandro Arevalo, MD, Fausto Loberiza, MD, Kai Fu, MD, Dennis Weisenburger, MD, Robert G. Bociek, MD, Martin Bast, BS, James O. Armitage, MD

Blood (2007) 110 (11): 3430.

https://doi.org/10.1182/blood.V110.11.3430.3430

Published: 2007

Journal Articles

Effect of T Cell Recovery on Overall Survival (OS) Following Pentostatin Conditioning for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).

James E. Talmadge, PhD, Ugur Coskun, PhD, Sarah Maas, MS, Orhan Turken, MD, Ziviko S. Pavletic, MD, Charles A. Kuszynski, PhD, Marcel Devetten, MD, Laura R. Schafer, MS, Lori Zobel, BS, Robert G. Bociek, MD

Blood (2007) 110 (11): 2994.

https://doi.org/10.1182/blood.V110.11.2994.2994

Published: 2007

Journal Articles

Mechanism of Alemtuzumab Depletion of T Cells in Stem Cell Products.

Dumrul Gulen, PhD, Robert G. Bociek, MD, Ugur Coskun, MD, Marcel P. Devetten, MD, James E. Talmadge, PhD

Blood (2006) 108 (11): 5176.

https://doi.org/10.1182/blood.V108.11.5176.5176

Published: 2006

Journal Articles

Differential T Cell Suppression by Two Different Pentostatin Conditioning Protocols for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).

Ugur Coskun, MD, Robert G. Bociek, MD, Zivko S. Pavletic, MD, Charlie Kuszynski, PhD, Marcel Devetten, MD, Laura Shafer, Lori Zobel, James E. Talmadge, PhD

Blood (2006) 108 (11): 5373.

https://doi.org/10.1182/blood.V108.11.5373.5373

Published: 2006

Journal Articles

Factors Affecting the Development of Atrial Fibrillation and Atrial Flutter (AF) Following Autologous Hematopoietic Stem Cell Transplantation (auto-HSCT).

Mary Lee H. Villanueva, MD, Fausto R. Loberiza, MD, MS, James O. Armitage, MD, Robert G. Bociek, MD, Apar Kishor Ganti, MD, James C. Lynch, PhD, Farhan Majeed, MD, Stefano R. Tarantolo, MD, Jo Torrey, RN, BSN, Julie M. Vose, MD, Philip J. Bierman, MD

Blood (2005) 106 (11): 1754.

https://doi.org/10.1182/blood.V106.11.1754.1754

Published: 2005

NARROW

Relapse from Complete Remission More Than 5 Years after Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Relapse Histology Most Commonly DLBCL with a Germinal Center B-Cell (GCB) Phenotype.

Effect of T Cell Recovery on Overall Survival (OS) Following Pentostatin Conditioning for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).

Mechanism of Alemtuzumab Depletion of T Cells in Stem Cell Products.

Differential T Cell Suppression by Two Different Pentostatin Conditioning Protocols for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).

Factors Affecting the Development of Atrial Fibrillation and Atrial Flutter (AF) Following Autologous Hematopoietic Stem Cell Transplantation (auto-HSCT).

Email alerts

ASH Publications

American Society of Hematology

Relapse from Complete Remission More Than 5 Years after Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Relapse Histology Most Commonly DLBCL with a Germinal Center B-Cell (GCB) Phenotype.

Effect of T Cell Recovery on Overall Survival (OS) Following Pentostatin Conditioning for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).

Mechanism of Alemtuzumab Depletion of T Cells in Stem Cell Products.

Differential T Cell Suppression by Two Different Pentostatin Conditioning Protocols for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).

Factors Affecting the Development of Atrial Fibrillation and Atrial Flutter (AF) Following Autologous Hematopoietic Stem Cell Transplantation (auto-HSCT).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only